INFORMATION & LABORATORY RESEARCH PURPOSES ONLY

Neuropeptides

MT-2 / Melanotan II Acetate

Cyclic melanocortin analogueSmall early human studies

What is it?

Melanotan II is a cyclic synthetic analogue in the melanocortin family. It is structurally different from Melanotan I and from bremelanotide. The attachment specifies an acetate form, but this is not enough to verify the complete material.

How it is studied

Melanocortin receptors have roles in pigmentation and central signalling. Early research therefore measured more than skin colour, including systemic effects. Broad receptor activity makes it inappropriate to describe MT-2 simply as a targeted tanning ingredient.

What the evidence shows

A small phase 1 pilot study investigated MT-2 in human volunteers. Further early research examined erectile responses in a small clinical experiment. These studies have limited size and scope and do not establish a routine cosmetic or wellness treatment.

Limitations & safety context

Early studies reported systemic effects such as nausea, yawning and spontaneous erections. A small trial cannot rule out uncommon or long-term harms. Neither the MT-1 medicine context nor bremelanotide’s evidence automatically applies to MT-2 supplier vials.

Listed specifications

ReferenceListed contents
ML1010 mg

Source-document quantities, not doses or a confirmation of stock. Identity, purity, component composition and suitability require separate documentation.

Back to homepage catalogue

Research information only. No dosing, administration or treatment advice.